Carlsmed (CARL) Net Cash Flow (2024 - 2026)

Carlsmed (CARL) has reported Net Cash Flow for 3 consecutive years, with -$26.8 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Net Cash Flow fell 168.8% year-over-year to -$26.8 million; the trailing twelve-month figure through Jun 2026 stood at $12.8 million (up 373.14% YoY), and the FY2025 full-year result was $45.7 million, up 39.01% from the prior year.
• Net Cash Flow retreated to -$26.8 million in Q2 2026 per CARL's latest filing, from -$12.8 million in the prior quarter.
• Across five years, Net Cash Flow topped out at $81.9 million in Q3 2025 and bottomed at -$29.6 million in Q4 2025.
• Historically, Net Cash Flow has averaged $1.0 million across 3 years, with a median of -$7.1 million in 2024.
• The widest YoY moves for Net Cash Flow: up 1201.67% in 2025, down 585.52% in 2025.
• Over 3 years, Net Cash Flow stood at -$4.3 million in 2024, then sank by 585.52% to -$29.6 million in 2025, then advanced by 9.49% to -$26.8 million in 2026.
• According to Business Quant data, Net Cash Flow over the past three periods registered -$26.8 million, -$12.8 million, and -$29.6 million for Q2 2026, Q1 2026, and Q4 2025 respectively.